IMUTEX
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine. The development of BIV and Zika vaccines are key public health priorities identified by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) in the United States.
IMUTEX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.imutex.com
Total Employee:
1+
Status:
Active
Contact:
+44 207 036 8550
Total Funding:
14 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Investors List
Official Site Inspections
http://www.imutex.com Semrush global rank: 5.4 M Semrush visits lastest month: 1.56 K
- Host name: 253.237.197.35.bc.googleusercontent.com
- IP address: 35.197.237.253
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
